Comparison of the effect of combined exercise and consumption of three types of tea on overweight men

Comparison of the effect of combined training and consumption of three types of tea on the serum levels of FGF21 and PGC1a in overweight and obese men

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230131057292N2

Enrollment

Registered

2024-08-20

Start date

2024-05-30

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and obesity. Obesity, unspecified

Interventions

Intervention 1: Intervention group: combined exercises + green tea for 8 weeks and will perform 3 times of combined exercises every week. The combined exercises of each session include 10 minutes of w

Eligibility

Sex/Gender

Male

Age

30 Years to 50 Years

Inclusion criteria

Inclusion criteria: Men aged between 30 and 50 years Body mass index between 25 and 35 kg/m2 Inactivity (less than 30 minutes of sports activity per week)

Exclusion criteria

Exclusion criteria: Taking any kind of medicine and food supplement Performing surgery to reduce obesity Consumption of alcoholic beverages and cigarettes Subjects' unwillingness to continue the research protocols Allergy to tea Participating in sports activities other than the sports program of the present study

Design outcomes

Primary

Measure	Time frame
Serum levels of PGC1a. Timepoint: 48 hours before and after the last training session after 12 hours of fasting. Method of measurement: Using the human ELISA diagnostic kit related to the variable.;Serum levels of FGF21. Timepoint: 48 hours before and after the last training session after 12 hours of fasting. Method of measurement: 48 hours before and after the last training session after 12 hours of fasting.	—

Measure

Time frame

Serum levels of PGC1a. Timepoint: 48 hours before and after the last training session after 12 hours of fasting. Method of measurement: Using the human ELISA diagnostic kit related to the variable.;Serum levels of FGF21. Timepoint: 48 hours before and after the last training session after 12 hours of fasting. Method of measurement: 48 hours before and after the last training session after 12 hours of fasting.

—

Secondary

Measure	Time frame
Weight changes. Timepoint: At the beginning of the study (before the start of the intervention) and 8 weeks after the start of the research. Method of measurement: scale.;Waist to hip ratio. Timepoint: At the beginning of the study (before the start of the intervention) and 8 weeks after the start of the research. Method of measurement: Waist to hip ratio.;Body mass index. Timepoint: At the beginning of the study (before the start of the intervention) and 8 weeks after the start of the research. Method of measurement: Bioelectrical impedance device.;Fat index. Timepoint: At the beginning of the study (before the start of the intervention) and 8 weeks after the start of the research. Method of measurement: Bioelectrical impedance device.	—

Measure

Time frame

Weight changes. Timepoint: At the beginning of the study (before the start of the intervention) and 8 weeks after the start of the research. Method of measurement: scale.;Waist to hip ratio. Timepoint: At the beginning of the study (before the start of the intervention) and 8 weeks after the start of the research. Method of measurement: Waist to hip ratio.;Body mass index. Timepoint: At the beginning of the study (before the start of the intervention) and 8 weeks after the start of the research. Method of measurement: Bioelectrical impedance device.;Fat index. Timepoint: At the beginning of the study (before the start of the intervention) and 8 weeks after the start of the research. Method of measurement: Bioelectrical impedance device.

—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactzahra Hosseini

University of Tehran

zarahosseini@ut.ac.ir+98 21 6111 8872

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026